Pregravid preparation as the main method of preventing undeveloped pregnancy

Cover Page

Cite item

Full Text

Abstract

How to make a pregravid women with the stood pregnancy in the anamnesis is the key to success in the fight against miscarriage. The testing outside of pregnancy, the identification of reasons for stopping a previous gestation, adherence to medical recommendations in the programme of preparation for future conception and implantation is a required step in the management of women who have had non-developing pregnancy. Periconceptional prevention is effective only at its beginning 3 months before conception and in the early stages of development of the embryo and fetus (12 weeks).The purpose of the study was improvement profilakticheskih activities based on identified pathogenetic mechanisms of occurrence of missed abortion. Aim of the study: to perfect the features of pregravid preparation for pregnant with undeveloping pregnancy in anamnesis on the basis of the educed nosotropic mechanisms of origin of this pathology, her intercommunication with a folats deficit. Materials and methods. Research was conducted in a few stages. On the first stage retrospectively on the basis of analysis 90 hospital charts are educed the supposed risk factors. On the second stage the exposure of reliable risk and development of algorithms of prognostication of undeveloping pregnancy (factors was conducted in 2 groups - basic (90 pregnant with stopping beating pregnancy) and control (30 pregnant with normally aleak pregnancy). The methods of prophylaxis of this pathology offered in high-risk of origin of stopping beating pregnancy groups. One of them was application of folates, namely vitamin-mineral complex before and after conception. Results. On the basis of undertaken studies multifactor genesis of missed miscarriage was confirmed, and the basic etiologic factors of origin of this pathology are educed. Stopping beating of pregnancy at anomalous karyotype takes place for certain before (6.2±0.8 weeks) what at normal karyotype (8.7±1.2 weeks). Cross-correlation connection was set between frequency of development of chromosomal anomalies and level of homocysteine from МТНFR677ТТ, level correlation of Spirmena equaled 0.84 - direct cross-correlation connection. As a result of undertaken a study one of methods of preparation application of folates offered in a kind vitamin-mineral complex for 16 weeks to conception and 12 weeks after conception. Conclusion. High-frequency of МТНFR677ТТ of heterogeneous or homozygous carriers educed for women with undeveloping pregnancy. Application of folates is in a vitamin-mineral complex, can be one of the most effective methods in the prophylaxis of early reproductive losses.

About the authors

L V Tkachenko

Volgograd State Medical University of Ministry of Health of the Russian Federation

Email: tkachenko.fuv@mail.ru
д-р мед. наук, проф., зав. каф. акушерства и гинекологии ФУВ 400131, Russian Federation, Volgograd, pl. Pavshikh bortsov, d. 1

T I Kostenko

Volgograd State Medical University of Ministry of Health of the Russian Federation

канд. мед. наук, доц. каф. акушерства и гинекологии ФУВ 400131, Russian Federation, Volgograd, pl. Pavshikh bortsov, d. 1

T V Skladanovskaya

Volgograd State Medical University of Ministry of Health of the Russian Federation

канд. мед. наук, доц. каф. акушерства и гинекологии ФУВ 400131, Russian Federation, Volgograd, pl. Pavshikh bortsov, d. 1

E A Khomich

Volgograd State Medical University of Ministry of Health of the Russian Federation

аспирант каф. акушерства и гинекологии ФУВ 400131, Russian Federation, Volgograd, pl. Pavshikh bortsov, d. 1

References

  1. Акушерство. Национальное руководство. Под ред. Э.К.Айламазяна, В.И.Кулакова, В.Е.Радзинского, Г.М.Савельевой. М.: ГЭОТАР-Медиа, 2014.
  2. Галина Т.В., Добрецова Т.А. Беременная XXI века: трудно как никогда. Информационный бюллетень. Под ред. В.Е.Радзинского. 2015
  3. Громова О.А., Торшин И.Ю., Тетруашвили Н.К., Лисицына Е.Ю. Систематический анализ взаимосвязи витаминов и пороков развития. Акуш. и гинекол. 2012.
  4. Доброхотова Ю.Э., Озерова Р.И., Джобаева Э.М. Неразвивающаяся беременность. Тромботические и клинико-иммунологические факторы. М., 2010.
  5. Ворсанова С.Г., Дышева Н.М., Никифорова O.K. и др. Цитогенетические особенности хориона при неразвивающейся беременности. Акуш. и гинекол. 2014; 2
  6. Preedy V.R. B vitamins and folate chemistry, analysis, function and effects. London: RSC, 2013.
  7. Ворсанова С.Г., Юров Ю.Б., Чернышов В.Н. Медицинская цитогенетика. Учебное пособие. М.: МЕДПРАКТИКА-М, 2006.
  8. Доброхотова Ю.Э., Джобава Э.М., Озерова Р.И. Неразвивающаяся беременность. М.: ГЭОТАР-Медиа, 2010.
  9. МАРС: Неразвивающаяся беременность, Status Praesens, 2015
  10. Andrew Ceisell Primary prevention of malformations: polivitamins or folacin. J Med Sci 2004.
  11. Doerfler W, Boem P. DNA methylation: development, genetic disiesis and cancer.Berlin. Springer, 2014.
  12. Новиков Е.И., Рухляда Н.Н., Глуховец Н.Г. Неразвивающаяся беременность первого триместра. Современные аспекты клинико-морфологической диагностики и лечения. Пособие для врачей. СПб.: НИИ скорой помощи им. И.И.Дженелидзе, 2012.
  13. Радзинский В.Е., Димитрова В.И., Майскова И.Ю. Неразвивающаяся беременность. М.: ГЭОТАР-Медиа, 2009.
  14. Kim M, Hong S et al. Homocysteine, folate and pregnancy outcome. J Obstent Gynaecol 2012.
  15. Mascarenhas M, Habeebullah S, Srihar M. Revisiting the role of first trimester homocysteine as an index of maternal and fetal outcome. J Pregnancy 2014.
  16. O'Donnell M. Why doctors don't read research papers? Scientific papers are not written to disseminate information. BMJ 2005; 330: 256.
  17. Suzomori N. Genetic factors as a cause of miscarriage. Curr Med Сhem 2010; 17.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).